Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury

Brain, Behavior, and Immunity

Volumn 25, Issue 6, 2011, Pages 1099-1112

  Esposito, Emanuela ^a   Paterniti, Irene ^a   Mazzon, Emanuela ^b   Genovese, Tiziana ^a   Di Paola, Rosanna ^b   Galuppo, Maria ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

CB2; GDNF; Mast cells; NGF; NT 3; Spinal cord injury

Indexed keywords

CANNABINOID 2 RECEPTOR; CHYMASE; DOPAMINE TRANSPORTER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; PALMIDROL; PEPTIDASE; PROTEIN TYROSINE KINASE; TRYPTASE;

ANEURYSM CLIP; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME RELEASE; INFLAMMATION; INJURY SEVERITY; LAMINECTOMY; MALE; MICROGLIA; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMMENDED DRUG DOSE; SPINAL CORD INJURY; THORACIC SPINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; CELL DEGRANULATION; CHYMASES; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG EVALUATION, PRECLINICAL; LAMINECTOMY; MALE; MAST CELLS; MICE; MICROGLIA; MYELITIS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PALMITIC ACIDS; RANDOM ALLOCATION; RECEPTOR, CANNABINOID, CB2; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES; SURGICAL INSTRUMENTS; THORACIC VERTEBRAE; TRYPTASES;

EID: 79960209448     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.006     Document Type: Article

References (66)

1. Aloe L., Leon A., Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993, 39(Spec. No.):C145-C147.
2. Andoh A., Deguchi Y., Inatomi O., Yagi Y., Bamba S., Tsujikawa T., Fujiyama Y. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol. Rep. 2006, 16:103-107.
3. Bao F., DeWitt D.S., Prough D.S., Liu D. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J. Neurosci. Res. 2003, 71:220-227.
4. Basso D.M., Fisher L.C., Anderson A.J., Jakeman L.B., McTigue D.M., Popovich P.G. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006, 23:635-659.
5. Berdyshev E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 2000, 108:169-190.
6. Berdyshev E.V., Boichot E., Germain N., Allain N., Anger J.P., Lagente V. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 1997, 330:231-240.
7. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 1998, 18:3251-3260.
8. Bilsland L.G., Dick J.R., Pryce G., Petrosino S., Di Marzo V., Baker D., Greensmith L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 2006, 20:1003-1005.
9. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 2003, 163:463-468.
10. Blesch A., Tuszynski M.H. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J. Comp. Neurol. 2003, 467:403-417.
11. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998, 394:277-281.
12. Calignano A., La Rana G., Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 2001, 419:191-198.
13. Conti S., Costa B., Colleoni M., Parolaro D., Giagnoni G. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 2002, 135:181-187.
14. Costa B., Comelli F., Bettoni I., Colleoni M., Giagnoni G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain 2008, 139:541-550.
15. Cravatt B.F., Saghatelian A., Hawkins E.G., Clement A.B., Bracey M.H., Lichtman A.H. Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc. Natl. Acad. Sci. USA 2004, 101:10821-10826.
16. Cuzzocrea S., Genovese T., Mazzon E., Crisafulli C., Min W., Di Paola R., Muia C., Li J.H., Esposito E., Bramanti P., Xu W., Massuda E., Zhang J., Wang Z.Q. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J. Pharmacol. Exp. Ther. 2006, 319:127-138.
17. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 2001, 53:135-159.
18. De Petrocellis L., Davis J.B., Di Marzo V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett. 2001, 506:253-256.
19. Del Fiacco M., Quartu M., Serra M.P., Follesa P., Lai M.L., Bachis A. Topographical localization of glial cell line-derived neurotrophic factor in the human brain stem: an immunohistochemical study of prenatal, neonatal and adult brains. J. Chem. Neuroanat. 2002, 23:29-48.
20. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Nat. Rev. Drug Discov. 2008, 7:438-455.
21. Di Marzo V., Melck D., De Petrocellis L., Bisogno T. Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins Other Lipid Mediat. 2000, 61:43-61.
22. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 1995, 92:3376-3380.
23. Farquhar-Smith W.P., Jaggar S.I., Rice A.S. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 2002, 97:11-21.
24. Farquhar-Smith W.P., Rice A.S. A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology 2003, 99:1391-1401.
25. Garcia-Ovejero D., Arevalo-Martin A., Petrosino S., Docagne F., Hagen C., Bisogno T., Watanabe M., Guaza C., Di Marzo V., Molina-Holgado E. The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol. Dis. 2009, 33:57-71.
26. Genovese T., Esposito E., Mazzon E., Di Paola R., Meli R., Bramanti P., Piomelli D., Calignano A., Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J. Pharmacol. Exp. Ther. 2008, 326:12-23.
27. Glaser J., Gonzalez R., Sadr E., Keirstead H.S. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J. Neurosci. Res. 2006, 84:724-734.
28. Gordon J.R., Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med. 1991, 174:103-107.
29. Hansen H.S. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp. Neurol. 2010, 224:48-55.
30. Klocker N., Braunling F., Isenmann S., Bahr M. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. NeuroReport 1997, 8:3439-3442.
31. Kownatzki E. Triggering of mast cells. Mol. Immunol. 1982, 19:1297-1300.
32. Lambert D.M., Di Marzo V. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?. Curr. Med. Chem. 1999, 6:757-773.
33. Lapointe N.P., Rouleau P., Ung R.V., Guertin P.A. Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates. J. Physiol. 2009, 587:1499-1511.
34. Laurikainen A., Hiltunen J.O., Vanhatalo S., Klinge E., Saarma M. Glial cell line-derived neurotrophic factor is expressed in penis of adult rat and retrogradely transported in penile parasympathetic and sensory nerves. Cell Tissue Res. 2000, 302:321-329.
35. Lim G., Sung B., Ji R.R., Mao J. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats. Pain 2003, 105:275-283.
36. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005, 67:15-19.
37. Maresz K., Carrier E.J., Ponomarev E.D., Hillard C.J., Dittel B.N. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 2005, 95:437-445.
38. Mazzari S., Canella R., Petrelli L., Marcolongo G., Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol. 1996, 300:227-236.
39. Mican J.M., Metcalfe D.D. Arthritis and mast cell activation. J. Allergy Clin. Immunol. 1990, 86:677-683.
40. Michaloudi H.C., Papadopoulos G.C. Mast cells in the sheep, hedgehog and rat forebrain. J. Anat. 1999, 195(Pt 4):577-586.
41. Onaivi E.S., Carpio O., Ishiguro H., Schanz N., Uhl G.R., Benno R. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann. NY Acad. Sci. 2008, 1139:426-433.
42. Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
43. Pejler G., Abrink M., Ringvall M., Wernersson S. Mast cell proteases. Adv. Immunol. 2007, 95:167-255.
44. Petrosino S., Palazzo E., de Novellis V., Bisogno T., Rossi F., Maione S., Di Marzo V. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 2007, 52:415-422.
45. Pezeshki G., Franke B., Engele J. GDNF elicits distinct immediate-early gene responses in cultured cortical and mesencephalic neurons. J. Neurosci. Res. 2003, 71:478-484.
46. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell 1997, 8:2631-2645.
47. Rice A.S., Farquhar-Smith W.P., Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:243-256.
48. Rivlin A.S., Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol. 1978, 10:38-43.
49. Romero J., Hillard C.J., Calero M., Rabano A. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res. Mol. Brain Res. 2002, 100:85-93.
50. Ross R.A., Brockie H.C., Pertwee R.G. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur. J. Pharmacol. 2000, 401:121-130.
51. Saarma M. GDNF - a stranger in the TGF-beta superfamily?. Eur. J. Biochem. 2000, 267:6968-6971.
52. Sariola H., Saarma M. Novel functions and signalling pathways for GDNF. J. Cell Sci. 2003, 116:3855-3862.
53. Scarampella F., Abramo F., Noli C. Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study. Vet. Dermatol. 2001, 12:29-39.
54. Schwab M.E. Increasing plasticity and functional recovery of the lesioned spinal cord. Prog. Brain Res. 2002, 137:351-359.
55. Shea T.B. Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. BioTechniques 1994, 16:1126-1128.
56. Shneider N.A., Brown M.N., Smith C.A., Pickel J., Alvarez F.J. Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev. 2009, 4:42.
57. Shoemaker J.L., Seely K.A., Reed R.L., Crow J.P., Prather P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem. 2007, 101:87-98.
58. Sirin B.H., Ortac R., Cerrahoglu M., Saribulbul O., Baltalarli A., Celebisoy N., Iskesen I., Rendeci O. Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol. 2002, 57:279-285.
59. Theodosiou M., Rush R.A., Zhou X.F., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve damage: role of nerve growth factor. Pain 1999, 81:245-255.
60. Trivedi N.N., Caughey G.H. Mast cell peptidases: chameleons of innate immunity and host defense. Am. J. Respir. Cell. Mol. Biol. 2010, 42:257-267.
61. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
62. Tsou K., Nogueron M.I., Muthian S., Sanudo-Pena M.C., Hillard C.J., Deutsch D.G., Walker J.M. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci. Lett. 1998, 254:137-140.
63. Witting A., Walter L., Wacker J., Moller T., Stella N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl. Acad. Sci. USA 2004, 101:3214-3219.
64. Wotherspoon G., Fox A., McIntyre P., Colley S., Bevan S., Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience 2005, 135:235-245.
65. Zhang J., Hoffert C., Vu H.K., Groblewski T., Ahmad S., O'Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci. 2003, 17:2750-2754.
66. Zuo Y., Perkins N.M., Tracey D.J., Geczy C.L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 2003, 105:467-479.